• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer

Guttman, Buschner & Brooks

  • Home
  • Areas of Practice
    • High Impact Litigation
    • Whistleblower and False Claim Cases
    • Employment Litigation and Civil Rights – Employees
    • Employment Counseling and Litigation – Employers
    • Corporate Governance
  • Successes
  • Articles
  • Attorneys
    • Justin S. Brooks
    • Traci L. Buschner
    • Judge Nancy Gertner (Ret.)
    • Dan Guttman
    • Reuben A. Guttman
    • Dr. Caroline Poplin
    • Elizabeth H. Shofner
    • Aaron Welo
  • Amicus
  • Videos
  • Contact Us
    • Twitter
    • Facebook
    • LinkedIn

July 26, 2017 By GBB Staff

Celgene to Pay $280 Million to Settle Fraud Suit Over Cancer Drugs

The pharmaceutical company Celgene has agreed to pay $280 million to settle claims that it marketed the cancer drugs Thalomid and Revlimid for unapproved uses, the company said on Tuesday.

Under the terms of the settlement, which resulted from a lawsuit filed by a whistle-blower — a former sales representative at Celgene — the company will pay $259.3 million to the United States and $20.7 million to 28 states and the District of Columbia.

. . .

“The company got the idea that it could be fast and loose with what it was saying about its drug because it was selling to cancer patients who might be in need,” Mr. Guttman said. “At the end of the day, what this is about is that even when you’re on life’s edge,” he added, a company “can’t break the law by off-label marketing a drug.”

. . .

The settlement was reached after federal prosecutors declined to intervene in the case, although they continued to monitor it. Under the federal False Claims Act, private citizens like Ms. Brown can bring a suit against companies in the United States and share in any recovery. The amount of her reward has not yet been determined, Mr. Guttman said.

. . .

Read the full story here.

Primary Sidebar

Information

  • Where to Start
  • Whistleblower Information
  • Federal & State False Claims Acts
  • Protecting Whistleblowers
  • rguttmanReuben A. Guttman
    Senior Founding Partner


    (202) 800-3002
    rguttman@gbblegal.com

    Practice Areas
    Consumer Law
    Complex Litigation
    Complex Employment and Labor
    Civil Rights

    Education
    Emory Law School (J.D., 1985)
    University of Rochester (BA, 1981)

    Admissions
    The State of Georgia
    The District of Columbia
    The Commonwealth of Pennsylvania
    The State of New Jersey
    The Supreme Court of the United States
    The United States District Courts for the
    - District of Columbia
    - District of New Jersey
    - District of Nebraska
    - Northern District of Georgia
    - District of Maryland
    - Western District of Michigan
    -Eastern District of Pennsylvania
    The United States Courts of Appeal for the
    - Third Circuit
    - Fourth Circuit
    - D.C. Circuit.

    Boards/Memberships
    Fellow of the American Bar Foundation

    American Bar Association Fellows


    Reuben A. Guttman
    Rated by Super Lawyers

    loading ...





Footer

Guttman, Buschner & Brooks PLLC

Washington DC Office NEW!
Embassy Row District
1509 22nd Street, NW
Washington, D.C. 20037
Phone: 202-800-3001



Pennsylvania Office: New!
450 N. Narberth Avenue
Suite 102
Narberth, PA 19072
(610) 547-9556
CLE: GBB partner, Reuben Guttman, and Professor JC Lore of Rutgers Law to present CLE covering topic in their book, Pretrial Advocacy, Wolters Kluwer-NITA (2021).” To register or learn More
More about the book here

Articles

The Travesty of The US News Rankings: How Legal Education Should Be Measured

Demanding more impact from impact litigation: lessons to be learned from multi-state opioid settlements

Webinar: Non-state actors and global environmental governance in China

More Articles

Copyright © 2023 · Guttman, Buschner & Brooks PLLC
Disclaimer